腫瘤指標淺談臨床科研

1、精選ppt 從腫瘤標志物淺談臨床科研從腫瘤標志物淺談臨床科研九區(qū)：方申存九區(qū)：方申存精選ppt住院號住院號標本標本CEACEANSENSECY211CY211SCCSCCCA125CA125CA199CA199121098胸水24.52202.541.7212240.1血2.37.082.340.9584.890.1122055胸水0.4916.4384.250.81290.32.44血0.89.382.510.4447.243.99122166胸水6.597.393.280.9146.2111.26血4.148.6856.141.4934.526.55122069胸水2.214.6676.9

2、12.378045.76血3.032.542.10.36142.615.27124406胸水0.898.0817.461.685248.23血1.6811.262.20.5171.7410.61124406胸水0.898.0817.461.68314.26.52血1.6811.262.20.5171.7410.61 127435胸水0.647.7611.850.74165.93.53血0.778.181.030.5762.266.09121128胸水0.383.0913.312.1379.32.87血0.5210.491.670.4489.665.89132990胸水0.618.9120.69

3、2.6118921.21血0.6313.521.230.53119.14.49132668胸水1.6623.7660.125.71508.20.6血2.8714.72.40.6377.721.61124028胸水1.573.167.513.2215542血1.139.4620.722675.43133960胸水0.997.8826.365.6598.994.42血1.389.53.50.2946.018.89結核性胸膜炎患者胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物 機制研究（動物或細胞實驗） 提出問題（TM 是否增高及意義）TM在矽肺血

4、清中是否增高（矽肺與正常人比較）TM在矽肺增高的意義（TM與矽肺嚴重性的相關性分析） 個案病例分析 大樣本分析比較 反向論證 TM為何增高或來源分析？ 比較灌洗液與血清TM濃度肺活檢免疫組化 熒光免疫雙染精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物1.矽肺與正常人血清中矽肺與正常人血清中TM比較比較精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物2.個案相關性研究（不同時期矽肺血清個案相關性研究（不同時期矽肺血清TM變化）變化）精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物3.大樣本相關性分析大樣本相關性分析精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物4.反向論證反向論證精選

5、ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物5.血清中血清中TM的來源（比較灌洗液和血清中的來源（比較灌洗液和血清中TM差別）差別）精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物6.血清中血清中TM的來源（肺活檢組織免疫組化）的來源（肺活檢組織免疫組化）精選ppt矽肺血清中腫瘤標志物矽肺血清中腫瘤標志物7.TM來源何種細胞（熒光免疫雙染）來源何種細胞（熒光免疫雙染）精選ppt住院號住院號標本標本CEACEANSENSECY211CY211SCCSCCCA125CA125CA199CA199121098胸水24.52202.541.7212240.1血2.37.082.340.9584.8

6、90.1122055胸水0.4916.4384.250.81290.32.44血0.89.382.510.4447.243.99122166胸水6.597.393.280.9146.2111.26血4.148.6856.141.4934.526.55122069胸水2.214.6676.912.378045.76血3.032.542.10.36142.615.27124406胸水0.898.0817.461.685248.23血1.6811.262.20.5171.7410.61124406胸水0.898.0817.461.68314.26.52血1.6811.262.20.5171.7410

7、.61 127435胸水0.647.7611.850.74165.93.53血0.778.181.030.5762.266.09121128胸水0.383.0913.312.1379.32.87血0.5210.491.670.4489.665.89132990胸水0.618.9120.692.6118921.21血0.6313.521.230.53119.14.49132668胸水1.6623.7660.125.71508.20.6血2.8714.72.40.6377.721.61124028胸水1.573.167.513.2215542血1.139.4620.722675.43133960胸

8、水0.997.8826.365.6598.994.42血1.389.53.50.2946.018.89結核性胸膜炎患者胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物精選ppt結核性胸膜炎患者胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物姓名姓名住院號住院號標本標本CEACEANSENSECY211CY211SCCSCCCA125CA125CA199CA199袁小露126914治療前胸水0.383.0913.312.1379.32.87兩周后胸水0.272.885.81.52139.72.92三周后胸水0.4321.543.431.4226.762.96王燕127435胸水0.647.761

9、1.850.74165.93.53一周后胸水0.5117.459.690.43120.22.92劉翠英128540胸水1.132.2228.180.49861.70.6二周后胸水1.89.39.630.6774.2720.86抗結核治療前后胸水中抗結核治療前后胸水中TM變化變化精選ppt結核性胸膜炎患者胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物1.血清血清CA125與肺結核與肺結核The value of CA-125 in the evaluation of tuberculosis activity.Respir Med. 2001;95(8):666-9.精選ppt結核性胸膜炎患者

10、胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物2.血清血清CA125與肺結核與肺結核Serum CA-125: biomarker of pulmonary tuberculosis activity and evaluation of response to treatment.Clin Invest Med. 2012;35(4):223-8.注：Group1:活動性肺結核；Group2：非活動性肺結核：Group3:正常人精選ppt結核性胸膜炎患者胸水中腫瘤標志物結核性胸膜炎患者胸水中腫瘤標志物3.血清血清CA125與肺結核與肺結核Serum CA-125: biomarker of pulmonary tuberculosis activity and evaluation of response to treatment.Cli